DE602007007934D1 - Imidazoazephinonverbindungen - Google Patents

Imidazoazephinonverbindungen

Info

Publication number
DE602007007934D1
DE602007007934D1 DE602007007934T DE602007007934T DE602007007934D1 DE 602007007934 D1 DE602007007934 D1 DE 602007007934D1 DE 602007007934 T DE602007007934 T DE 602007007934T DE 602007007934 T DE602007007934 T DE 602007007934T DE 602007007934 D1 DE602007007934 D1 DE 602007007934D1
Authority
DE
Germany
Prior art keywords
imidazoazephinonverbindungen
compounds
formula
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007007934T
Other languages
English (en)
Inventor
Mark Spyvee
Boris Seletsky
Shawn Schiller
Francis Fang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai R&D Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co Ltd filed Critical Eisai R&D Management Co Ltd
Publication of DE602007007934D1 publication Critical patent/DE602007007934D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE602007007934T 2006-05-26 2007-05-24 Imidazoazephinonverbindungen Active DE602007007934D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80877006P 2006-05-26 2006-05-26
PCT/US2007/012298 WO2007139833A2 (en) 2006-05-26 2007-05-24 Imidazoazephinone compounds

Publications (1)

Publication Number Publication Date
DE602007007934D1 true DE602007007934D1 (en) 2010-09-02

Family

ID=38668997

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007007934T Active DE602007007934D1 (en) 2006-05-26 2007-05-24 Imidazoazephinonverbindungen

Country Status (7)

Country Link
US (1) US7985746B2 (de)
EP (1) EP2021003B1 (de)
JP (1) JP2009538312A (de)
AT (1) ATE474574T1 (de)
DE (1) DE602007007934D1 (de)
ES (1) ES2347837T3 (de)
WO (1) WO2007139833A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009538308A (ja) * 2006-05-26 2009-11-05 エーザイ・アール・アンド・ディー・マネジメント株式会社 イミダゾアゼピノン化合物
US20090197867A1 (en) * 2007-11-15 2009-08-06 Mark Spyvee Enantiomerically enriched imidazoazepinone compounds
JP2011503182A (ja) * 2007-11-15 2011-01-27 エーザイ・アール・アンド・ディー・マネジメント株式会社 使用方法
EP2220087A1 (de) * 2007-11-15 2010-08-25 Eisai R&D Management Co., Ltd. Enantiomerenangereicherte imidazoazepinonverbindungen
JP2011504878A (ja) * 2007-11-26 2011-02-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 イミダゾアゼピノン化合物の製造方法
MX2011005346A (es) * 2008-11-23 2011-06-16 Pfizer Lactamas como inhibidores de beta secretasa.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2010742A1 (en) * 1989-03-03 1990-09-03 Kenji Koga Azacyclooctadiene compound and pharmaceutical use
JPH04266886A (ja) 1991-02-20 1992-09-22 Eisai Co Ltd アザシクロオクタジエン誘導体
EP1619193A4 (de) 2003-04-18 2010-08-11 Ono Pharmaceutical Co Spiropiperidinverbindung und deren medizinische verwendung
AU2006206186A1 (en) * 2005-01-20 2006-07-27 President And Fellows Of Harvard College Modulation of Th2 lineage commitment by T-bet
TW200724140A (en) * 2005-05-27 2007-07-01 Eisai Co Ltd Hydantoin compounds
JP2009538308A (ja) * 2006-05-26 2009-11-05 エーザイ・アール・アンド・ディー・マネジメント株式会社 イミダゾアゼピノン化合物

Also Published As

Publication number Publication date
US20090131405A1 (en) 2009-05-21
ATE474574T1 (de) 2010-08-15
JP2009538312A (ja) 2009-11-05
WO2007139833A3 (en) 2008-01-31
EP2021003A2 (de) 2009-02-11
EP2021003B1 (de) 2010-07-21
WO2007139833A2 (en) 2007-12-06
US7985746B2 (en) 2011-07-26
ES2347837T3 (es) 2010-11-04

Similar Documents

Publication Publication Date Title
TW200716606A (en) Chemical compounds
TW200800963A (en) Chemical compounds
HK1113352A1 (en) Chemical compounds
HK1114375A1 (en) Chemical compounds
GB0625648D0 (en) Compounds
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
PH12014500053A1 (en) Proteasome inhibitors
MX2009006704A (es) Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
TNSN08444A1 (en) Bicyclic derivatives as cetp inhibitors
MY153915A (en) Organic compounds
IN2012DN01233A (de)
MX2009006706A (es) Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos.
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
TN2011000291A1 (en) Purine compounds
UA95644C2 (ru) Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
MY162146A (en) Pharmaceutical composition
EA200901133A1 (ru) Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение
TW200745122A (en) New compounds I
JO3007B1 (ar) مركبات و تركيبات كمثبطات كيناز بروتين
SG158091A1 (en) Imidazoazepinone compounds
EP2091328A4 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
MY167898A (en) Co-crystals and salts of ccr3-inhibitors
TW200738627A (en) Trialkylsilyl-indoles
DE602007007934D1 (en) Imidazoazephinonverbindungen